All In Biotech

Drug Trial Radar · NCT06012721

Effect of Food on the Pharmacokinetics of ORIC-114

A Phase 1, Randomized, Open-Label, Crossover Study Evaluating the Effect of Food on the Pharmacokinetics of ORIC-114 Tablet Formulation in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Jan 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Sep 11, 2023

Primary completion

Nov 23, 2023

Study completion Nov 23, 2023

Sponsor

Lead sponsor
ORIC PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A randomized, 2-part, 2-sequence, 2-period, open-label, crossover study evaluating the effect of food on the pharmacokinetics (PK) of ORIC-114 tablet formulation in healthy adult subjects.

Conditions

  • Food Effect in Healthy Participants

Interventions

  • ORIC-114Drug

    Food effect healthy subjects

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum plasma concentration (Cmax)Time frame: 14 days
  2. Time of maximum observed concentration (Tmax)Time frame: 14 days
  3. Area under the curve (AUC)Time frame: 14 days
  4. Apparent plasma terminal elimination half-life (t1/2)Time frame: 14 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Nucleus Network Pty Ltd., 235 Ryrie St

    Geelong, Victoria, Australia

  • Nucleus Network Pty Ltd., Level 5, Burnet Tower, 89 Commercial Rd

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.